155 related articles for article (PubMed ID: 16740647)
1. Opioid disposition in human sweat after controlled oral codeine administration.
Schwilke EW; Barnes AJ; Kacinko SL; Cone EJ; Moolchan ET; Huestis MA
Clin Chem; 2006 Aug; 52(8):1539-45. PubMed ID: 16740647
[TBL] [Abstract][Full Text] [Related]
2. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
[TBL] [Abstract][Full Text] [Related]
3. Drug testing with alternative matrices II. Mechanisms of cocaine and codeine deposition in hair.
Joseph RE; Höld KM; Wilkins DG; Rollins DE; Cone EJ
J Anal Toxicol; 1999 Oct; 23(6):396-408. PubMed ID: 10517543
[TBL] [Abstract][Full Text] [Related]
4. Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry.
Huestis MA; Oyler JM; Cone EJ; Wstadik AT; Schoendorfer D; Joseph RE
J Chromatogr B Biomed Sci Appl; 1999 Oct; 733(1-2):247-64. PubMed ID: 10572984
[TBL] [Abstract][Full Text] [Related]
5. Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration.
Kacinko SL; Barnes AJ; Schwilke EW; Cone EJ; Moolchan ET; Huestis MA
Clin Chem; 2005 Nov; 51(11):2085-94. PubMed ID: 16166169
[TBL] [Abstract][Full Text] [Related]
6. Sweat testing in opioid users with a sweat patch.
Kintz P; Tracqui A; Mangin P; Edel Y
J Anal Toxicol; 1996 Oct; 20(6):393-7. PubMed ID: 8889674
[TBL] [Abstract][Full Text] [Related]
7. Monitoring pregnant women's illicit opiate and cocaine use with sweat testing.
Brunet BR; Barnes AJ; Choo RE; Mura P; Jones HE; Huestis MA
Ther Drug Monit; 2010 Feb; 32(1):40-9. PubMed ID: 19927046
[TBL] [Abstract][Full Text] [Related]
8. Excretion of Delta9-tetrahydrocannabinol in sweat.
Huestis MA; Scheidweiler KB; Saito T; Fortner N; Abraham T; Gustafson RA; Smith ML
Forensic Sci Int; 2008 Jan; 174(2-3):173-7. PubMed ID: 17481836
[TBL] [Abstract][Full Text] [Related]
9. Qualitative detection of opiates in sweat by EIA and GC-MS.
Fogerson R; Schoendorfer D; Fay J; Spiehler V
J Anal Toxicol; 1997 Oct; 21(6):451-8. PubMed ID: 9323525
[TBL] [Abstract][Full Text] [Related]
10. Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration.
Barnes AJ; Smith ML; Kacinko SL; Schwilke EW; Cone EJ; Moolchan ET; Huestis MA
Clin Chem; 2008 Jan; 54(1):172-80. PubMed ID: 17981924
[TBL] [Abstract][Full Text] [Related]
11. Detection of codeine and phenobarbital in sweat collected with a sweat patch.
Kintz P; Tracqui A; Jamey C; Mangin P
J Anal Toxicol; 1996; 20(3):197-201. PubMed ID: 8735203
[TBL] [Abstract][Full Text] [Related]
12. Disposition of MDMA and metabolites in human sweat following controlled MDMA administration.
Barnes AJ; De Martinis BS; Gorelick DA; Goodwin RS; Kolbrich EA; Huestis MA
Clin Chem; 2009 Mar; 55(3):454-62. PubMed ID: 19168553
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of immunoassays for semiquantitative detection of cocaine and metabolites or heroin and metabolites in extracts of sweat patches.
Moody DE; Cheever ML
J Anal Toxicol; 2001 Apr; 25(3):190-7. PubMed ID: 11327351
[TBL] [Abstract][Full Text] [Related]
14. Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration.
Kim I; Barnes AJ; Oyler JM; Schepers R; Joseph RE; Cone EJ; Lafko D; Moolchan ET; Huestis MA
Clin Chem; 2002 Sep; 48(9):1486-96. PubMed ID: 12194925
[TBL] [Abstract][Full Text] [Related]
15. Validated gas chromatographic-negative ion chemical ionization mass spectrometric method for delta(9)-tetrahydrocannabinol in sweat patches.
Saito T; Wtsadik A; Scheidweiler KB; Fortner N; Takeichi S; Huestis MA
Clin Chem; 2004 Nov; 50(11):2083-90. PubMed ID: 15271860
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of 6-acetylmorphine in morphine-positive oral fluid specimens.
Presley L; Lehrer M; Seiter W; Hahn D; Rowland B; Smith M; Kardos KW; Fritch D; Salamone S; Niedbala RS; Cone EJ
Forensic Sci Int; 2003 Apr; 133(1-2):22-5. PubMed ID: 12742685
[TBL] [Abstract][Full Text] [Related]
17. Application of sweat patch screening for 16 drugs and metabolites using a fast and highly selective LC-MS/MS method.
Koster RA; Alffenaar JW; Greijdanus B; VanDerNagel JE; Uges DR
Ther Drug Monit; 2014 Feb; 36(1):35-45. PubMed ID: 24071814
[TBL] [Abstract][Full Text] [Related]
18. Drug testing with alternative matrices I. Pharmacological effects and disposition of cocaine and codeine in plasma, sebum, and stratum corneum.
Joseph RE; Oyler JM; Wstadik AT; Ohuoha C; Cone EJ
J Anal Toxicol; 1998; 22(1):6-17. PubMed ID: 9491963
[TBL] [Abstract][Full Text] [Related]
19. Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing.
Preston KL; Huestis MA; Wong CJ; Umbricht A; Goldberger BA; Cone EJ
J Anal Toxicol; 1999 Sep; 23(5):313-22. PubMed ID: 10488917
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart Opiate Microplate EIA and GC-MS following controlled codeine administration.
Barnes AJ; Kim I; Schepers R; Moolchan ET; Wilson L; Cooper G; Reid C; Hand C; Huestis MA
J Anal Toxicol; 2003 Oct; 27(7):402-7. PubMed ID: 14606992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
